NCT06970665 - A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Geographic AtrophyAge-Related Macular Degeneration

Interventions

DRUG

avacincaptad pegol

intravitreal injection

Trial Locations (12)

RECRUITING

Fukushima Medical University Hospital, Fukushima

RECRUITING

Kagawa University Hospital, Kita-gun

RECRUITING

Yokohama City University Medical Center, Yokohama

RECRUITING

Kyoto University Hospital, Kyoto

RECRUITING

Mie University Hospital, Tsu

RECRUITING

University of the Ryukyus hospital, Ginowan-shi

RECRUITING

The University of Osaka Hospital, Suita-shi

RECRUITING

Seirei Hamamatsu General Hospital, Hamamatsu

RECRUITING

Jichi Medical University Hospital, Shimotsuke-shi

RECRUITING

Nihon University Hospital, Chiyoda-ku

RECRUITING

Toyama University Hospital, Toyama

RECRUITING

University Of Yamanashi Hospital, Chuo-shi